NOVELLI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.805
EU - Europa 6.710
AS - Asia 1.229
OC - Oceania 129
AF - Africa 44
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.946
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.779
RU - Federazione Russa 2.115
PL - Polonia 1.763
IE - Irlanda 666
IT - Italia 606
SE - Svezia 415
SG - Singapore 387
UA - Ucraina 385
DE - Germania 316
HK - Hong Kong 306
CN - Cina 188
FI - Finlandia 173
GB - Regno Unito 149
AU - Australia 122
IN - India 115
JO - Giordania 62
TR - Turchia 61
VN - Vietnam 50
FR - Francia 31
ID - Indonesia 28
CA - Canada 26
CH - Svizzera 23
SC - Seychelles 22
CI - Costa d'Avorio 21
BE - Belgio 20
ES - Italia 17
NL - Olanda 16
AR - Argentina 14
KR - Corea 9
NZ - Nuova Zelanda 7
BR - Brasile 6
JP - Giappone 6
PE - Perù 6
RO - Romania 4
AM - Armenia 3
IQ - Iraq 3
PK - Pakistan 3
EU - Europa 2
HU - Ungheria 2
LB - Libano 2
NO - Norvegia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IS - Islanda 1
LV - Lettonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 18.946
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.644
Warsaw 1.762
Fairfield 1.186
Chandler 698
Dublin 663
Jacksonville 615
Woodbridge 606
Ashburn 568
Seattle 531
Cambridge 510
Wilmington 409
Houston 406
Singapore 291
Ann Arbor 210
Princeton 201
Altamura 198
Lawrence 197
Hong Kong 138
Boston 128
Boardman 119
Florence 117
Melbourne 115
Mumbai 105
Medford 88
Buffalo 70
San Diego 65
Beijing 64
Moscow 55
Shanghai 52
Milan 43
Dong Ket 39
Norwalk 34
Falls Church 31
Izmir 31
New York 31
Los Angeles 28
Jakarta 26
Auburn Hills 22
Abidjan 21
Hillsboro 19
Bern 18
Yubileyny 18
Brussels 17
Frankfurt Am Main 17
Guangzhou 17
Redwood City 17
Toronto 16
Andover 15
Helsinki 15
Phoenix 14
West Jordan 14
Barcelona 13
London 13
Bologna 10
Buenos Aires 10
Kent 10
Laurel 9
Rome 9
Armagh 8
Saint Petersburg 8
Tappahannock 7
Iksan 6
Lima 6
Mountain View 6
Auckland 5
Dong Nai 5
Catania 4
Giugliano in Campania 4
Lastra a Signa 4
Munich 4
Munro 4
Ottawa 4
Pune 4
Salerno 4
San Mateo 4
Tokyo 4
Verona 4
Ankara 3
Arezzo 3
Baghdad 3
Bari 3
Campo Grande 3
Fiesole 3
Hanoi 3
Hounslow 3
Istres 3
Kilburn 3
Leiden 3
Multan 3
Nanjing 3
Pavia 3
Vancouver 3
Yerevan 3
Amsterdam 2
Beirut 2
Bhopal 2
Boretto 2
Budapest 2
Campinas 2
Canicattì 2
Totale 13.545
Salva come PNG Salva come JPEG
Nome #
Changes in ceftriaxone pharmacokinetics/pharmacodynamics during the early phase of sepsis: a prospective, experimental study in the rat 283
Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia. 274
Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review 262
Breakthrough bacteremia by linezolid-susceptible Enterococcus faecalis under linezolid treatment in a severe polytrauma patient. 249
Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012 237
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example. 233
Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus 232
Intraoperative positive fluid balance improves tissue diffusion of ceftizoxime. 232
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer. 231
Cost of care and antibiotic prescribing attitudes for community-acquired complicated intra-abdominal infections in Italy: a retrospective study. 227
Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis. 223
Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot. 222
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now? 218
Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients 180
Cefazolin bolus and continuous administration for elective cardiacsurgery: improved pharmacokinetic and pharmacodynamic parameters 161
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? 157
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 151
Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics 138
Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate. 136
Choosing Wisely: The Top-5 Recommendations from the Italian Panel of the National Guidelines for the Management of Acute Pharyngitis in Children 136
Daptomycin serum levels in critical patients undergoing continuous renal replacement 131
Ertapenem peritoneal fluid concentrations in adult surgical patients. 131
The role of lomefloxacin in the treatment of chronic prostatitis. 130
Ceftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation in a lung transplant recipient 127
Inhibitory activity of diluted wine on bacterial growth: the secret of water purification in antiquity. 126
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy 126
Bacillus subtilis spores as a natural pro-host oral agent. Preliminary data in children. 126
Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial. 124
Caspofungin PK in critically ill patients after the first and fourth doses: suggestions for therapeutic drug monitoring? 122
In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogens 122
Azithromycin concentrations in serum and bronchial secretions of patients with cystic fibrosis 121
Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice 121
The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach. 121
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 120
Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants. 119
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 117
In vitro brodimoprim activity on nosocomial bacterial strains. 116
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. 115
Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration? 113
Relaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathway 112
Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections 112
In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin. 112
Pharmacological rationale for antibiotic treatment of intra-abdominal infections. 111
Pharmacokinetic evaluation of meropenem and imipenem in critically-ill patients with sepsis. 111
Voriconazole in clinical practice 111
Adverse effects of macrolide antibacterials. 109
Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of caspofungin in a population of critically ill septic patients 109
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration? 108
Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections. 107
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). 107
Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. 106
Ofloxacin concentrations in human inflamed pericoronal tissue after oral administration. 106
Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. 105
Guidelines for the diagnosis and treatment of acute and subacute rhinosinusitis in children. 105
Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis. 104
Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group 104
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 104
Daptomycin plus trimethoprim/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis. 104
Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients. 103
Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. 103
Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration. 102
Efficacy of caspofungin against Aspergillus terreus. 102
Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery. 102
Antimicrobial prophylaxis in surgery: the role of pharmacokinetics. 101
The role of PK/PD-based strategies to preserve new molecules against multi-drug resistant gram-negative strains 100
In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. 98
Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients. 98
Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis 98
Postantibiotic leukocyte enhancement of meropenem against Gram-positive and Gram-negative strains 98
The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion. 98
Description of the disease and diagnostic and epidemiologic aspects 98
Use of the parenteral antibiotic Ertapenem as short term prophylaxis in bariatric surgery: a pharmacokinetic-pharmacodynamic study in class III obese female patients 98
Development of an algorithm for the management of cervical lymphadenopathy in children: Consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society of Pediatric Otorhinolaryngology 98
Pharmacokinetics and blister fluid penetration of brodimoprim in adults. 98
Prevention of recurrent respiratory infections: Inter-society Consensus 98
Tissue distribution of cefotetan in patients with Crohn's disease. 97
Dibekacin in vitro activity on recently isolated bacterial strains from various clinical materials. 97
Aspetti farmacologici delle cefalosporine 97
Ciprofloxacin inhibition of cefoxitin betalactamase induction in an Enterobacter cloacae strain. 97
Etiology issues and problems of antibiotic resistance 97
Comparative in vitro activity of a new quinolone, AM-1091. 96
Betalactam therapy and intestinal flora. 95
Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial. 95
Fluorochinoloni. 95
Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Treatment 95
Moxalactam pharmacokinetics in healthy volunteers and patients with renal insufficiency. 94
Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use 94
Actual role of older oral antibiotics in the treatment of resistant Urinary Tract Infections (UTIs) 94
Farmacologia degli antibiotici nelle infezioni della cute e dei tessuti molli 94
Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis. 93
The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic? 93
Interactions between triazoles and amphotericin B against Cryptococcus neoformans. 93
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection. 93
Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial. 93
Regional and systemic prophylaxis with teicoplanin in total knee arthroplasty: a tissue penetration study 92
Prerogative farmacologiche delle cefalosporine orali: ruolo del cefaclor 92
Candida glabrata Prosthetic Hip Infection 92
Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate 92
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. 91
Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System. 91
Totale 12.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.960 0 0 0 0 0 402 303 402 322 212 264 55
2020/20212.138 208 168 208 236 64 222 62 214 136 342 93 185
2021/20221.163 40 131 93 45 43 53 35 90 56 37 212 328
2022/20232.886 309 532 88 203 255 551 361 152 281 18 88 48
2023/2024977 62 127 208 54 83 124 25 165 20 54 25 30
2024/20255.960 264 820 535 1.100 2.183 1.058 0 0 0 0 0 0
Totale 19.129